Retrieve available abstracts of 43 articles: HTML format
Single Articles
May 2025
AUDSLEY J, Avihingsanon A, Li X, Edwards R, et al Kinetics and predictors of Hepatitis B surface antigen (HBsAg) loss after
commencing HBV-active antiretroviral therapy (ART) in the setting of HIV-and
chronic HBV co-infection.
Clin Infect Dis. 2025 May 31:ciaf281. doi: 10.1093. PubMedAbstract available
HALL EW, Sandul AL, Kamili S, Cartwright EJ, et al Cost-Effectiveness Analysis of Testing Approaches for Diagnosis of Hepatitis C
Among US Adults.
Clin Infect Dis. 2025 May 21:ciaf166. doi: 10.1093. PubMedAbstract available
KU JH, Gu YM, Hoke CF, Tseng HF, et al Screening and vaccination rates for tetanus, hepatitis A, and hepatitis B among
individuals with substance use disorders who are hospitalized in an integrated
U.S. health system.
Clin Infect Dis. 2025 May 20:ciaf251. doi: 10.1093. PubMedAbstract available
April 2025
SHEMUEL J, Krawiec A, Kalauokalani D, Lucas KD, et al A Case-Control Study of Hepatitis C Virus Re-infection in Incarcerated Patients
in California Receiving Medication for Opioid Use Disorder.
Clin Infect Dis. 2025 Apr 15:ciaf192. doi: 10.1093. PubMedAbstract available
THOMAS AM, Litwin AH, Tsui JI, Sprecht-Walsh S, et al Retreatment of Hepatitis C Virus Among People Who Inject Drugs.
Clin Infect Dis. 2025 Apr 15:ciaf082. doi: 10.1093. PubMedAbstract available
CARSON JM, Dore GJ Learning From the Gaps: Rethinking Hepatitis C Virus Retreatment for People Who
Inject Drugs.
Clin Infect Dis. 2025 Apr 15:ciaf083. doi: 10.1093. PubMed
TOY M, Hutton D, Teshale E, Thompson WW, et al Cost-Effectiveness of One-time Universal Testing for Hepatitis D among Adults
living with Chronic Hepatitis B in the United States.
Clin Infect Dis. 2025 Apr 8:ciaf181. doi: 10.1093. PubMedAbstract available
February 2025
AZZELLINO G, Ginaldi L, De Martinis M A Biosocial Roadmap to Tackle the Burden of Hepatitis C Virus Infections That
Ensures Health Equity for All.
Clin Infect Dis. 2025 Feb 12:ciae623. doi: 10.1093. PubMed
January 2025
SERUMONDO J, Barebwanuwe P, Sheferaw ED, Iyonizera J, et al Introducing Sofosbuvir/Velpatasvir + Ribavirin as a Generic Retreatment Regimen
for Hepatitis C: Evaluation of a Government Program in Rwanda.
Clin Infect Dis. 2025 Jan 29:ciae637. doi: 10.1093. PubMedAbstract available
BARRE T, Ramier C, Wittkop L, Sogni P, et al Low CD4 cell count is associated with post-hepatitis C virus cure mortality in
people living with HIV (ANRS CO13 HEPAVIH cohort).
Clin Infect Dis. 2025 Jan 15:ciaf016. doi: 10.1093. PubMed
MATELSKI A, Gregoire B, Beste LA, Varley CD, et al Analysis of Repeat Hepatitis C Viremia After Sustained Virologic Response in a
Large Cohort of U.S. Veterans.
Clin Infect Dis. 2025 Jan 9:ciaf008. doi: 10.1093. PubMedAbstract available
HUANG YS, Sun HY, Ho SY, Lin KY, et al Incidence and outcome of hepatitis D virus infection in people with HIV in the
era of tenofovir-containing antiretroviral therapy.
Clin Infect Dis. 2025 Jan 2:ciae655. doi: 10.1093. PubMedAbstract available
December 2024
HAN WM, Solomon S, Smeaton L, Avihingsanon A, et al Reinfection and resistance associated substitutions following a minimal
monitoring approach for HCV treatment in MINMON trial.
Clin Infect Dis. 2024 Dec 20:ciae627. doi: 10.1093. PubMedAbstract available
CHAPPELL CA, Kiser JJ, Brooks KM, Randolph R, et al Sofosbuvir/Velpatasvir Pharmacokinetics, Safety, and Efficacy in Pregnant People
with Hepatitis C Virus.
Clin Infect Dis. 2024 Dec 17:ciae595. doi: 10.1093. PubMedAbstract available
November 2024
SEAMAN A, Cook R, Leichtling G, Herink MC, et al Peer-assisted telemedicine for hepatitis C in people who use drugs: A randomized
controlled trial.
Clin Infect Dis. 2024 Nov 27:ciae520. doi: 10.1093. PubMedAbstract available
AKIYAMA MJ, Thornton K, Voyles N, Vincent L, et al Meeting People Where They Are: The Roles of Peer Navigation and Telemedicine for
HCV Elimination.
Clin Infect Dis. 2024 Nov 27:ciae521. doi: 10.1093. PubMed
PERERA H, Keeshan A, Imsirovic H, Patern J, et al Rapid HCV Engagement and Treatment in Hospitalized Patients.
Clin Infect Dis. 2024 Nov 21:ciae574. doi: 10.1093. PubMed
EPSTEIN RL, Munroe S, Taylor LE, Duryea PR, et al Clinical- and Cost-Effectiveness of Liver Disease Staging in Hepatitis C Virus
Infection: A Microsimulation Study.
Clin Infect Dis. 2024 Nov 13:ciae485. doi: 10.1093. PubMedAbstract available
October 2024
INZAULE S, Easterbrook P, Latona A, Ford NP, et al Prevalence of Drug Resistance Associated Substitutions in Persons With Chronic
Hepatitis C Infection and Virological Failure Following Initial or Re-treatment
With Pan-genotypic Direct-Acting Antivirals: A Systematic Review and
Meta-analysis.
Clin Infect Dis. 2024 Oct 3:ciae431. doi: 10.1093. PubMedAbstract available
BIONDI BE, Munroe S, Lavarin C, Curtis MR, et al Racial and Ethnic Disparities in Hepatitis C Care in Reproductive-Aged Women With
Opioid Use Disorder.
Clin Infect Dis. 2024 Oct 2:ciae426. doi: 10.1093. PubMedAbstract available
September 2024
MARTIN-CARMONA J, Corma-Gomez A, Tellez F, Arenga-Barrios D, et al No impact of HIV coinfection on the mortality in patients with hepatitis C virus
infection after sustained virological response.
Clin Infect Dis. 2024 Sep 18:ciae473. doi: 10.1093. PubMedAbstract available
MACISAAC MB, Papaluca T, McDonald L, Craigie A, et al Long-term outcomes of a decentralized, nurse-led, statewide model of care for
hepatitis C among people in prison in Victoria, Australia.
Clin Infect Dis. 2024 Sep 16:ciae471. doi: 10.1093. PubMedAbstract available
July 2024
FRIEDMAN JR, Abramovitz D, Skaathun B, Rangel G, et al Illicit Fentanyl Use and Hepatitis C Virus Seroconversion Among People Who Inject
Drugs in Tijuana and San Diego: Results From a Binational Cohort Study.
Clin Infect Dis. 2024 Jul 30:ciae372. doi: 10.1093. PubMedAbstract available
FIERER DS, Carollo JR, Rodriguez-Caprio G, Radix A, et al Hepatitis C Virus Reinfection Among Men Who Have Sex With Men With HIV in New
York City.
Clin Infect Dis. 2024 Jul 18:ciae297. doi: 10.1093. PubMedAbstract available
June 2024
RUSS RK, Vandehei HM, Golovkina MI, Mogallapalli H, et al Hepatitis B-CpG vaccine series for healthcare workers who are hepatitis B vaccine
nonresponders.
Clin Infect Dis. 2024 Jun 17:ciae320. doi: 10.1093. PubMedAbstract available
MIDGARD H, Malme KB, Finbraten AK, Dalgard O, et al Treatment completion and SVR in the context of HCV elimination: Time to let go of
the reins?
Clin Infect Dis. 2024 Jun 2:ciae298. doi: 10.1093. PubMed
May 2024
PAN CQ, Zhu L, Yu AS, Zhao Y, et al Tenofovir Alafenamide versus Tenofovir Disoproxil Fumarate for Preventing
Vertical Transmission in Chronic Hepatitis B Mothers: A Systematic Review and
Meta-Analysis.
Clin Infect Dis. 2024 May 28:ciae288. doi: 10.1093. PubMedAbstract available
LO RE V 3RD, Price JC, Schmitt S, Terrault N, et al The Obstacle is the Way: Finding a Path to Hepatitis C Elimination.
Clin Infect Dis. 2024 May 16:ciae231. doi: 10.1093. PubMed
ZHANG HL, Mock M, Bushman L, Anderson PL, et al Cumulative tenofovir exposure among patients with human immunodeficiency
virus/hepatitis B co-infection with differential viral suppression.
Clin Infect Dis. 2024 May 3:ciae241. doi: 10.1093. PubMedAbstract available
April 2024
HOOD RB, Norris AH, Shoben A, Miller WC, et al Forecasting Hepatitis C Virus Status for Children in the United States: A
Modeling Study.
Clin Infect Dis. 2024 Apr 17:ciae157. doi: 10.1093. PubMedAbstract available
CAFARDI JM, Lin HT, Lange L, Kelley L, et al Vertical Transmission of Hepatitis C Virus Among Women with a History of
Injection Opioid Use.
Clin Infect Dis. 2024 Apr 5:ciae177. doi: 10.1093. PubMedAbstract available
SU WJ, Chen HL, Chen SF, Liu YL, et al Optimization of Mother-to-Child Hepatitis B Virus Prevention Program: Integration
of Maternal Screening and Infant Post-vaccination Serologic Testing.
Clin Infect Dis. 2024 Apr 2:ciae176. doi: 10.1093. PubMedAbstract available
March 2024
BERTUMEN JB, Pascopella L, Han E, Glenn-Finer R, et al Epidemiology and Treatment Outcomes of Tuberculosis with Chronic Hepatitis B
Infection-California, 2016-2020.
Clin Infect Dis. 2024 Mar 26:ciae169. doi: 10.1093. PubMedAbstract available
GREBELY J Point-of-care testing for hepatitis C infection: A critical building block for
the foundation to achieve elimination.
Clin Infect Dis. 2024 Mar 21:ciae156. doi: 10.1093. PubMed
MCCARTNEY EM, Ralton L, Dawe J, Richmond J, et al Point of care testing for hepatitis C in the priority settings of mental health,
prisons and drug & alcohol facilities - the PROMPt Study.
Clin Infect Dis. 2024 Mar 21:ciae155. doi: 10.1093. PubMedAbstract available
February 2024
Correction to: Estimated Prevalence and Awareness of Hepatitis C Virus Infection
Among US Adults: National Health and Nutrition Examination Survey, January
2017-March 2020.
Clin Infect Dis. 2024 Feb 23:ciad783. doi: 10.1093. PubMed
January 2024
LITWIN AH, Akiyama MJ US Veterans Health Administration Hepatitis C Virus (HCV) Program - A Model for
National HCV Elimination though Patient-Centered Medical Homes.
Clin Infect Dis. 2024 Jan 27:ciae028. doi: 10.1093. PubMed
VARLEY CD, Lowy E, Cartwright EJ, Morgan TR, et al Success of the US Veterans Health Administration's Hepatitis C Virus Care
Continuum in the Direct-acting Antiviral Era.
Clin Infect Dis. 2024 Jan 27:ciae025. doi: 10.1093. PubMedAbstract available
November 2023
VINIKOOR MJ, Hamusonde K, Muula G, Asombang M, et al Long-term hepatitis B and liver outcomes among adults taking tenofovir-containing
antiretroviral therapy for HBV/HIV coinfection in Zambia.
Clin Infect Dis. 2023 Nov 24:ciad654. doi: 10.1093. PubMedAbstract available
MIDGARD H, Malme KB, Pihl CM, Berg-Pedersen RM, et al Opportunistic treatment of hepatitis C infection among hospitalized people who
inject drugs (OPPORTUNI-C): A stepped wedge cluster randomized trial.
Clin Infect Dis. 2023 Nov 22:ciad711. doi: 10.1093. PubMedAbstract available
ROWAN SE, Wyles DL Don't put off until tomorrow what you can do today: Hospital admissions as an
opportunity to treat hepatitis C.
Clin Infect Dis. 2023 Nov 22:ciad712. doi: 10.1093. PubMed
October 2023
WONG RJ, Yang Z, Cheung R Disparities in Antiviral Treatment among Adults with Hepatitis B Cirrhosis: An
Analysis of the National Veterans Affairs Cohort.
Clin Infect Dis. 2023 Oct 9:ciad617. doi: 10.1093. PubMedAbstract available
September 2023
YANG J, Lo NC, Dankwa EA, Donnelly CA, et al Determining herd immunity thresholds for hepatitis A virus transmission to inform
vaccination strategies among people who inject drugs in 16 U.S. States.
Clin Infect Dis. 2023 Sep 21:ciad552. doi: 10.1093. PubMedAbstract available